首页|重组人干扰素α2b阴道泡腾片治疗宫颈高危型HPV感染的效果

重组人干扰素α2b阴道泡腾片治疗宫颈高危型HPV感染的效果

扫码查看
目的:探讨重组人干扰素α2b阴道泡腾片治疗宫颈高危型人乳头瘤病毒(HPV)感染的效果.方法:选取2021 年 2 月—2022 年 2 月无锡市康复医院收治的 124 例宫颈高危型HPV感染患者作为研究对象,按随机数表法将 124 例患者分为观察组(n=62)和对照组(n=62).对照组采用膦甲酸钠氯化钠注射液治疗,观察组采用重组人干扰素α2b阴道泡腾片治疗.比较两组HPV转阴率、临床效果、血清炎症因子及T淋巴细胞水平.结果:治疗后,观察组HPV转阴率为 90.32%,高于对照组的 72.58%,差异有统计学意义(χ2=5.024,P=0.025);观察组总有效率为 87.10%,高于对照组的69.35%,差异有统计学意义(χ2=6.508,P=0.011);治疗后,两组白细胞介素-1(IL-1)、肿瘤坏死因子-α(TNF-α)较治疗前降低,且观察组低于对照组,差异有统计学意义(P<0.05).治疗后,两组T淋巴细胞水平较治疗前改善,且观察组CD8+水平低于对照组,而CD4+、CD4+/CD8+及CD3+水平高于对照组,差异有统计学意义(P<0.05).结论:重组人干扰素α2b阴道泡腾片能提高宫颈高危型HPV感染患者细胞免疫能力,降低血清炎症因子水平,进而提高HPV转阴率,缓解临床症状.
Effect of Recombinant Human Interferon α2b Vaginal Effervescent Tablets in the Treatment of Cervical High-risk HPV Infection
Objective:To explore the effect of Recombinant Human Interferon α2b Vaginal Effervescent Tablets in the Treatment of cervical high-risk human papillomavirus(HPV)infection.Method:A total of 124 patients with cervical high-risk HPV infection who admitted to Wuxi Rehabilitation Hospital from February 2021 to February 2022 were selected as the research objects,124 patients were divided into the observation group(n=62)and control group(n=62)according to the random number table method.The control group was treated with Sodium Chlorophosphate Injection,while the observation group was treated with Recombinant Human Interferon α2b Vaginal Effervescent Tablets.The HPV clearance rate,clinical effect,serum inflammatory factor and T lymphocyte levels of two groups were compared.Result:The HPV clearance rate in the observation group was 90.32%,which was higher than 72.58%in the control group,the difference was statistically significant(χ2=5.024,P=0.025).The total effective rate in the observation group was 87.10%,which was higher than 69.35%in the control group,the difference was statistically significant(χ2=6.508,P=0.011).After treatment,the levels of interleukin-1(IL-1)and tumor necrosis factor-α(TNF-α)in two groups were lower than those before treatment,and which in the observation group were lower than those in the control group,the differences were statistically significant(P<0.05).After treatment,the levels of T lymphocytes in two groups were improved compared with those before treatment,and the level of CD8+ in the observation group was lower than that in the control group,while the levels of CD4+,CD4+/CD8+ and CD3+ were higher than those in the control group,the differences were statistically significant(P<0.05).Conclusion:Recombinant Human Interferon α2b Vaginal Effervescent Tablets can improve the cellular immunity of patients with cervical high-risk HPV infection,reduce the level of serum inflammatory factors,thereby increase the HPV clearance rate and relieving clinical symptoms.

Cervical high-risk HPV infectionRecombinant Human Interferon α2b Vaginal Effervescent TabletsHPV clearance rateInflammatory factors

刘英、陈亚楠

展开 >

无锡市康复医院 江苏 无锡 214001

无锡市梁溪区黄巷街道社区卫生服务中心

宫颈高危型人乳头瘤病毒感染 重组人干扰素α2b阴道泡腾片 人乳头瘤病毒转阴率 炎症因子

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(1)
  • 21